894 related articles for article (PubMed ID: 26910804)
1. Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.
Biton Y; Baman JR; Polonsky B
Heart Fail Rev; 2016 Jul; 21(4):433-46. PubMed ID: 26910804
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
[TBL] [Abstract][Full Text] [Related]
3. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
[TBL] [Abstract][Full Text] [Related]
4. Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT.
Sherazi S; Shah F; Kutyifa V; McNitt S; Aktas MK; Polonsky B; Zareba W; Goldenberg I
JACC Clin Electrophysiol; 2019 Oct; 5(10):1172-1181. PubMed ID: 31648742
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of implantable cardiac resynchronization therapy plus defibrillator for primary prevention of sudden cardiac death in patients with mild heart failure: an updated meta-analysis.
Sun WP; Li CL; Guo JC; Zhang LX; Liu R; Zhang HB; Zhang L
Heart Fail Rev; 2016 Jul; 21(4):447-53. PubMed ID: 27043219
[TBL] [Abstract][Full Text] [Related]
6. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
[TBL] [Abstract][Full Text] [Related]
7. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
Samii SM
Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
[TBL] [Abstract][Full Text] [Related]
8. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
[TBL] [Abstract][Full Text] [Related]
10. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
Narducci ML; Biffi M; Ammendola E; Vado A; Campana A; Potenza DR; Iori M; Zanon F; Zacà V; Zoni Berisso M; Bertini M; Lissoni F; Bandini A; Malacrida M; Crea F
Europace; 2018 Sep; 20(9):1475-1483. PubMed ID: 29186401
[TBL] [Abstract][Full Text] [Related]
11. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
[TBL] [Abstract][Full Text] [Related]
12. Newer Indications for ICD and CRT.
Merriam JA; Rajendra AB; Gold MR
Cardiol Clin; 2014 May; 32(2):181-90. PubMed ID: 24793795
[TBL] [Abstract][Full Text] [Related]
13. Defibrillators: Selecting the Right Device for the Right Patient.
Al-Khatib SM; Friedman P; Ellenbogen KA
Circulation; 2016 Nov; 134(18):1390-1404. PubMed ID: 27799257
[TBL] [Abstract][Full Text] [Related]
14. Update of implantable cardioverter/defibrillator and cardiac resynchronization therapy in heart failure.
Rami T; Shih HT
Curr Opin Cardiol; 2004 May; 19(3):264-9. PubMed ID: 15096960
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
[TBL] [Abstract][Full Text] [Related]
16. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.
Sengupta J; Abdelhadi R
Curr Opin Cardiol; 2013 May; 28(3):337-43. PubMed ID: 23549236
[TBL] [Abstract][Full Text] [Related]
17. Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D.
Sebag FA; Lellouche N; Chen Z; Tritar A; O'Neill MD; Gill J; Wright M; Leclercq C; Rinaldi CA
J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1368-75. PubMed ID: 25066404
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy.
Levine YC; Matos J; Rosenberg MA; Manning WJ; Josephson ME; Buxton AE
Heart Rhythm; 2016 Feb; 13(2):490-7. PubMed ID: 26409099
[TBL] [Abstract][Full Text] [Related]
20. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
